Ransomware Group: WORLDLEAKS

VICTIM NAME: InnoMedica

NOTE: No files or stolen information are [exfiltrated/downloaded/taken/hosted/seen/reposted/disclosed] by RedPacket Security. Any legal issues relating to the content of the files should be directed at the attackers directly, not RedPacket Security. This blog is simply posting an editorial news post informing that a company has fallen victim to a ransomware attack. RedPacket Security is in no way affiliated or aligned with any ransomware threat actors or groups and will not host infringing content. The information on this page is fully automated and redacted whilst being scraped directly from the WORLDLEAKS Onion Dark Web Tor Blog page.

AI Generated Summary of the Ransomware Leak Page

The ransomware leak pertains to InnoMedica, a Swiss-based biopharmaceutical company specializing in treatments for serious medical conditions, including cancer and neurological disorders. The leak was discovered on July 21, 2025, and involves sensitive information potentially related to the company’s research and development activities. The victim’s primary focus is on advanced medical technologies, with noteworthy products such as Talidox, a targeted nanomedical cancer therapy. The leak appears to be part of a larger campaign by the group “worldleaks,” aimed at exposing proprietary data from organizations in the healthcare sector. No explicit details of the compromised data have been publicly disclosed, but the leak indicates the presence of data leaks and possible download links.

The leak page includes references to technical or internal information, and possibly screenshots of internal documents or communications, although specific images or documents are not available. The attack represents a significant cybersecurity event for InnoMedica, given the sensitive nature of their research and their focus on next-generation medical treatments. The incident underscores the importance of cybersecurity measures within healthcare organizations, especially those involved in innovative medical research. The leak’s discovery date suggests that the malicious actors gained access prior to July 21, 2025, and the data may contain valuable insights into the company’s proprietary projects and technological advancements.